Cutaneous Pain in Atopic Dermatitis: Mental Health Burden
Journal of Clinical Medicine · 13.04.2026 · 15 (8) · 2938
DOI: 10.3390/jcm15082938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.04.2026. Verfasst von Magdalena Kotewicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Magdalena Kotewicz Private Practice, 50-203 Wrocław, Poland. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is often associated with cutaneous pain. The objective of this study was to evaluate the impact of cutaneous pain on the prevalence of anxiety, depression, quality of life (QoL) and stigmatization in patients with AD.
Methods
A cross-sectional study was conducted on a group of 113 adults with AD (61% females; mean age 34.48 ± 13.20 years). The severity of AD was evaluated using the Eczema Area and Severity Index (EASI). The intensity of cutaneous pain in the past week was measured using a Numerical Rating Scale (NRS), a Short Form McGill Pain Questionnaire (SF-MPQ) and a Visual Analogue Scale (VAS). Psychosocial burden was evaluated using the Hospital Anxiety and Depression Scale (HADS), the Anxiety Generalized Disorder-7 (GAD-7), the Patient Health Questionnaire-9 (PHQ-9), the Dermatology Life Quality Index (DLQI) and the 6-Item Stigmatization Scale (6-ISS).
Results
Individuals with AD who reported cutaneous pain in the past week scored significantly higher in HADS (p < 0.001), HADS-A (p < 0.001), HADS-D (p = 0.002), GAD-7 (p < 0.001), PHQ-9 (p < 0.001), DLQI (p < 0.001) and 6-ISS (p < 0.001) than the rest of the cohort. More individuals with cutaneous pain had anxiety (36 (48.0%) vs. 7 (18.4%), p = 0.002), depression (21 (28.0%) vs. 2 (5.3%), p = 0.006) and abnormal HADS scores (46 (61.3%) vs. 9 (23.7%), p < 0.001) compared to the rest of participants. Significant correlations were observed between all studied pain assessment tools and all studied psychometric assessments.
Conclusions
The prevalence and severity of anxiety, depression, stigmatization, and impaired QoL are higher in adults with AD suffering from cutaneous pain compared to those without pain. This symptom is significantly associated with disease burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Magdalena Kotewicz Private Practice, 50-203 Wrocław, Poland.
- Dermatology Clinic, Görlitz Municipal Hospital, 02828 Görlitz, Germany.
- Department of Dermatology, Jagiellonian University, 31-503 Kraków, Poland.
- Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wroclaw University of Science and Technology, 51-377 Wroclaw, Poland.
- Department of Dermato-Venereology, 4th Military Hospital, 50-981 Wroclaw, Poland.
ORCID-Profile: Jacek C Szepietowski
Förderung
- Wroclaw Medical University
Zitieren
APA
Kotewicz, M., Mazgaj, J., Jaworek, A. K., & Szepietowski, J. C. (2026). Cutaneous Pain in Atopic Dermatitis: Mental Health Burden. Journal of Clinical Medicine, 15(8), 2938. https://doi.org/10.3390/jcm15082938
Vancouver
Kotewicz M, Mazgaj J, Jaworek AK, Szepietowski JC. Cutaneous Pain in Atopic Dermatitis: Mental Health Burden. Journal of Clinical Medicine. 2026;15(8):2938. doi:10.3390/jcm15082938
BibTeX
@article{Kotewicz2026,
author = {Kotewicz, Magdalena and Mazgaj, Joanna and Jaworek, Andrzej K and Szepietowski, Jacek C},
title = {Cutaneous Pain in Atopic Dermatitis: Mental Health Burden},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {8},
pages = {2938},
doi = {10.3390/jcm15082938}
}
EUVIMED